Back to News
Market Impact: 0.15

SS Innovations Responds To FDA Request For Additional Information On SSi Mantra Robotic System

Source: Nasdaq

Healthcare & BiotechRegulation & LegislationTechnology & Innovation

SS Innovations International (SSII) submitted its response on October 5, 2026, to the U.S. FDA’s request for additional information regarding its 510(k) submission for the SSi Mantra surgical robotic system. The announcement reports a regulatory-process update but does not state an FDA decision or clearance.

AllMind Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Trial

Market Sentiment

Overall Sentiment

neutral

Sentiment Score

0.00

Ticker Sentiment

SSII0.10

More News

From AllMind Research

Browse all research